Artemisinin's molecular symphony: illuminating pathways for cancer therapy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Artemisinin (ART), derived from Artemisia annua, shows promise as an anticancer agent by affecting cell signaling, apoptosis, and angiogenesis. Further research is needed to validate its therapeutic potential in various cancers.
Area Of Science
- Molecular Biology
- Pharmacology
- Oncology
Background
- Artemisinin (ART), a natural compound from Artemisia annua, is known for antimalarial and antimicrobial activities.
- Emerging research indicates significant anticancer potential for Artemisinin.
- Understanding ART's molecular mechanisms is key to exploring its therapeutic applications in cancer.
Purpose Of The Study
- To review the molecular mechanisms of Artemisinin's anticancer effects.
- To elucidate ART's impact on key cancer pathways and processes.
- To explore ART's potential in combination cancer therapy.
Main Methods
- Literature review of studies investigating Artemisinin's anticancer properties.
- Analysis of molecular pathways modulated by ART, including cell signaling, apoptosis, and autophagy.
- Examination of ART's effects on angiogenesis, oxidative stress, and DNA damage in cancer cells.
Main Results
- Artemisinin modulates critical cell signaling pathways involved in cancer progression.
- ART induces apoptosis and autophagy, leading to cancer cell death.
- ART inhibits angiogenesis and impacts oxidative stress and DNA damage in cancer cells, with potential synergistic effects with conventional drugs.
Conclusions
- Artemisinin exhibits multifaceted anticancer effects through various molecular mechanisms.
- ART presents a promising candidate for novel cancer therapeutic strategies.
- Further clinical validation and research are essential to fully harness ART's therapeutic potential across diverse cancer types.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...